Arrival of direct antiviral agent therapy for hepatitis C sparks debate of who to treat first
For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, ...
May 25, 2011
1
0